Pacira Pharmaceuticals ^Public

Pacira Pharmaceuticals is a specialty pharmaceutical company that focuses on postsurgical innovation. They develop and manufacture injectable pharmaceutical products using their proprietary multivesicular liposome (pMVL) technology, which allows for controlled release of drugs over time without altering their molecular structure. Their main product, EXPAREL, is a long-acting local analgesic that is administered during surgery to control pain and reduce the need for opioids. Pacira Pharmaceuticals aims to address the overreliance on opioids in the postsurgical setting and mitigate the associated risks of adverse events, long-term use, misuse, and addiction. They are also the parent company of Pacira, Inc.